IMULYZIN, Injekční suspenze
IMULYZIN, Injekční suspenze
Authorised
- Lysine
- Polyclonal immunoglobulins, Bovine
Product identification
Medicine name:
IMULYZIN, Injekční suspenze
Active substance:
- Lysine
- Polyclonal immunoglobulins, Bovine
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Lysine0.16/gram(s)1.00Dose
-
Polyclonal immunoglobulins, Bovine0.06/gram(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
-
Intramuscular use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Package description:
- Available only in Czech
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/338/92-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 16/01/2026
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 16/01/2026
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 16/01/2026